US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mistras Group Inc

7.96

+0.25003.24%

Volume:159.57K

Turnover:1.26M

Market Cap:249.39M

PE:16.83

High:8.02

Open:7.75

Low:7.69

Close:7.71

Loading ...

Overview Company News Filings

Owning 44% shares,institutional owners seem interested in Mistras Group, Inc. (NYSE:MG),

Simply Wall St.

NYSE Content Advisory: Pre-Market update + NYSE-listed Delta Air Lines reports earnings

MISTRAS Group Rings Bell at NYSE, Reaffirming Its Leadership in Data-Driven Asset Protection

China-owned British car brand MG aims to double South-east Asia sales to 100,000 in next three years

Cartesian Therapeutics’ Descartes-08 Observed to Provide Deep and Sustained Benefits Through Month 12 After a Single Course of Therapy in Phase 2b Myasthenia Gravis Trial

Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights

New nipocalimab data and real-world research at AAN 2025 highlight positive Phase 3 results and commitment to people living with generalized myasthenia gravis (gMG)

Brazil Potash Announces Participation In Diversibram 2025

FDA Accepts Sanofi's Filing for Multiple Sclerosis Drug Tolebrutinib

IMVT Unlikely to Pursue Batoclimab for MG & CIDP Despite Success

Immunovant Ditches Seeking FDA Approval For Batoclimab For Two Autoimmune Disorders Despite Positive Phase 3 Data

Immunovant’s Batoclimab Shows Promising Efficacy in MG and CIDP, Justifying Buy Rating

Immunovant’s batoclimab shows ‘impressive’ efficacy in MG, says H.C. Wainwright

Roivant says Immunovant announces results from Phase 3 study of batoclimab in MG

Roivant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Programs

Immunovant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Programs

Is Now The Time To Look At Buying Magna International Inc. (TSE:MG)?

Simply Wall St.

Market Chatter: Meritz Financial Group Subsidiary Drops MG Non-Life Acquisition Amid Union Opposition

MT Newswires Live

MISTRAS Group Inc (MG) Q4 2024 Earnings Call Highlights: Record Operating Income and Strategic ...

Q4 2024 Mistras Group Inc Earnings Call

Thomson Reuters StreetEvents

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/MG/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MG\",,,,,undefined,":{"symbol":"MG","market":"US","secType":"STK","nameCN":"Mistras Group Inc","latestPrice":7.96,"timestamp":1747166400000,"preClose":7.71,"halted":0,"volume":159569,"delay":0,"floatShares":16581817,"shares":31329814,"eps":0.472838,"marketStatus":"Pre-Mkt","change":0.25,"latestTime":"05-14 06:40:05 EDT","open":7.75,"high":8.02,"low":7.685,"amount":1261795.872734,"amplitude":0.04345,"askPrice":9.6,"askSize":200,"bidPrice":7,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.472838,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1747229400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1254974400000,"exchange":"NYSE","adjPreClose":7.96,"postHourTrading":{"tag":"盘后","latestPrice":7.96,"preClose":7.96,"latestTime":"16:18 EDT","volume":5003,"amount":39823.88,"timestamp":1747167532008},"volumeRatio":0.7793182666520512,"impliedVol":0.4606,"impliedVolPercentile":0.4739},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MG\",,,,,undefined,":{"symbol":"MG","floatShares":16581817,"roa":"4.62%","roe":"7.66%","lyrEps":0.613011,"volumeRatio":0.7793182666520512,"shares":31329814,"dividePrice":0,"high":8.02,"amplitude":0.04345,"preClose":7.71,"low":7.685,"week52Low":7.06,"pbRate":"1.26","psRate":"0.35","week52High":12.435,"institutionHeld":0,"latestPrice":7.96,"committee":-0.333333,"eps":0.472838,"divideRate":0,"volume":159569,"delay":0,"ttmEps":0.472838,"open":7.75,"prevYearClose":9.06,"prevWeekClose":7.82,"prevMonthClose":9.12,"prevQuarterClose":10.58,"fiveDayClose":9.59,"twentyDayClose":9.46,"sixtyDayClose":10.08},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MG\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526797552","title":"Owning 44% shares,institutional owners seem interested in Mistras Group, Inc. (NYSE:MG),","url":"https://stock-news.laohu8.com/highlight/detail?id=2526797552","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526797552?lang=en_us&edition=fundamental","pubTime":"2025-04-10 18:32","pubTimestamp":1744281148,"startTime":"0","endTime":"0","summary":"Significantly high institutional ownership implies Mistras Group's stock price is sensitive to their trading actions. 50% of the business is held by the top 13 shareholders. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.Every investor in Mistras Group, Inc.  should be aware of the most powerful shareholder groups. With 44% stake, institutions possess the maximum shares in the company. Put another way, the group faces the maximum upside potential .Given the vast amount of money and research capacities at their disposal, institutional ownership tends to carry a lot of weight, especially with individual investors. As a result, a sizeable amount of institutional money invested in a firm is generally viewed as a positive attribute.What Does The Institutional Ownership Tell Us About Mistras Group?Researching institutional ownershi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/owning-44-shares-institutional-owners-103228473.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NYSE","IE00B66KJ199.SGD","IE00B7SZL793.SGD","IE00B19Z4B17.USD","BK4123","MG","IE0031619046.USD"],"gpt_icon":0},{"id":"2526078369","title":"NYSE Content Advisory: Pre-Market update + NYSE-listed Delta Air Lines reports earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2526078369","media":"CNW Group","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526078369?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:55","pubTimestamp":1744203300,"startTime":"0","endTime":"0","summary":"NEW YORK, April 9, 2025 /CNW/ -- The New York Stock Exchange  provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market updatefor market insights before trading begins.Kristen Scholer delivers the pre-market update on April 9th. Overnight, markets in Asia were mixed and European indexes trended downward following the S&P closing below 5000 for the first time in a year.This morning, in response to U.S. raising tariffs to 104% on Chinese imports, China announced an increase of its tariffs on U.S. goods to 84%.Delta Air Lines  reported earnings today and noted it is too early to update its full-year guidance to the ongoing trade policy negotiations, but the airline still expects to be profitable for 2025.Opening BellMISTRAS Group, Inc.  to celebrate the launch of MISTRAS Data Solutions. Closing BellTD SYNNEX  in celebration of their 2025 Investor Day.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nyse-content-advisory-pre-market-125500217.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NYSE","SNX","ICE","MG","DAL"],"gpt_icon":0},{"id":"2526368008","title":"MISTRAS Group Rings Bell at NYSE, Reaffirming Its Leadership in Data-Driven Asset Protection","url":"https://stock-news.laohu8.com/highlight/detail?id=2526368008","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526368008?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:00","pubTimestamp":1744200000,"startTime":"0","endTime":"0","summary":"PRINCETON JUNCTION, N.J., April 09, 2025  -- MISTRAS Group, Inc. , the leading “one source” multinational provider of integrated technology-enabled asset protection solutions, will ring the opening bell at the New York Stock Exchange today, celebrating growing interest in, and adoption of, its asset protection solutions in energy, manufacturing, and aerospace and defense.MISTRAS Group leads with a data-driven approach across its portfolio of asset protection solutions, extending its expertise in maximizing the safety and operational uptime for critical industrial and civil assets across industries. With manufacturing looking to return to the U.S., a renewed commitment to energy, and the growing need for asset protection worldwide, MISTRAS is well-positioned for expansion and growth in 2025.MISTRAS Group works with many of the largest companies to solve complex challenges, both in the U.S. and around the world, to provide asset protection services and solutions. From ensuring safety in ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mistras-group-rings-bell-nyse-120000614.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B7SZL793.SGD","ESG","IE0031619046.USD","IE00B66KJ199.SGD","BK4123","MG","NYSE","IE00B19Z4B17.USD"],"gpt_icon":0},{"id":"2526352483","title":"China-owned British car brand MG aims to double South-east Asia sales to 100,000 in next three years","url":"https://stock-news.laohu8.com/highlight/detail?id=2526352483","media":"businesstimes","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526352483?lang=en_us&edition=fundamental","pubTime":"2025-04-09 08:25","pubTimestamp":1744158301,"startTime":"0","endTime":"0","summary":"It will add two more factories in region; offer EVs, hybrids and conventional cars ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"bustime_highlight","url":"https://www.businesstimes.com.sg/international/asean/china-owned-british-car-brand-mg-aims-double-south-east-asia-sales-100000-next-three-years","rn_cache_url":null,"customStyle":"","selectors":"body","filters":"","directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.businesstimes.com.sg/international/asean/china-owned-british-car-brand-mg-aims-double-south-east-asia-sales-100000-next-three-years","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bustime_highlight","symbols":["MG"],"gpt_icon":0},{"id":"2525893441","title":"Cartesian Therapeutics’ Descartes-08 Observed to Provide Deep and Sustained Benefits Through Month 12 After a Single Course of Therapy in Phase 2b Myasthenia Gravis Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2525893441","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525893441?lang=en_us&edition=fundamental","pubTime":"2025-04-08 19:00","pubTimestamp":1744110000,"startTime":"0","endTime":"0","summary":"After a single course of therapy, Descartes-08-treated participants were observed to sustain deep responses through long-term follow-up, with an average 4.8-point reduction in MG-ADL at Month 12. Deepest and most compelling sustained responses observed in Descartes-08-treated participants who did not have prior exposure to biologic therapies, with an average 7.1-point reduction in MG-ADL and 57% of patients in this subgroup maintaining minimum symptom expression at Month 12. Safety profile consistent with previously reported data and continues to support outpatient administration. In the Phase 2b double-blind, placebo-controlled, crossover trial, a total of 36 heavily pretreated, highly symptomatic participants with MG were randomized 1:1 to receive either Descartes-08 or placebo administered as six weekly outpatient infusions without preconditioning chemotherapy. As previously announced, the trial met its primary endpoint and demonstrated a safety profile supporting outpatient adminis","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cartesian-therapeutics-descartes-08-observed-110000924.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B66KJ199.SGD","BK4123","RNAC","MG","LU2065731478.USD","DSGX","CRS","IE0031619046.USD","BK4006","IE00B19Z4B17.USD","MGC","IE00B7SZL793.SGD","IE0009354923.USD","BK4023","BK4139"],"gpt_icon":0},{"id":"2522330921","title":"Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2522330921","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522330921?lang=en_us&edition=fundamental","pubTime":"2025-03-27 04:01","pubTimestamp":1743019260,"startTime":"0","endTime":"0","summary":"Differentiated development program includes two Nkarta clinical trials and two investigator-sponsored trials of NKX019 in rheumatic and neurological diseases. Initial data for NKX019 in multiple autoimmune indications expected in second half of 2025. Restructuring and workforce reduction of 34% , including freezing of some future hires, to extend cash runway by more than one year to enable clinical milestones while having ample cash runway following the realization of those milestones. Cash balance of $380.5 million on December 31, 2024, including cash, cash equivalents and investments, expected to fund operations into 2029. NKX019 is an allogeneic, off-the-shelf, chimeric antigen receptor  NK-cell therapy candidate engineered to deplete CD19-positive cells in B-cell mediated autoimmune disease. The approach leverages the potential advantages of NK cell therapy, including deep and rapid B-cell killing, a lower risk of cytokine release syndrome and neurotoxicity, the opportunity for pot","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nkarta-reports-fourth-quarter-full-200100807.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4230","IE00B19Z4B17.USD","IE00B7SZL793.SGD","BK4022","BK4077","IE0031619046.USD","IE00B66KJ199.SGD","BK4139","SLE","MG","BK4505","BK4123","CAR","NKTX"],"gpt_icon":0},{"id":"2522804933","title":"New nipocalimab data and real-world research at AAN 2025 highlight positive Phase 3 results and commitment to people living with generalized myasthenia gravis (gMG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522804933","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522804933?lang=en_us&edition=fundamental","pubTime":"2025-03-26 20:03","pubTimestamp":1742990580,"startTime":"0","endTime":"0","summary":"Oral presentation features new data from the 24-week pivotal Vivacity-MG3 study which show sustained disease control through treatment with nipocalimab on the clinician-assessed QMGa score in antibody positive adult patients: anti-AChR+, anti-MuSK+, anti-LRP4+. Nipocalimab data demonstrate longer-term sustained disease control as measured by MG-ADLb and QMG scores from the ongoing open-label extension  of the Vivacity-MG3 study. Johnson & Johnson filed a Biologics License Application  for nipocalimab in August 2024 and was granted U.S. FDA Priority Review for the treatment of gMG. Real-world studies highlight the unmet need of patients living with gMG, including those who are pregnant or receiving steroids. Oral and poster presentations include data from the pivotal Phase 3 Vivacity-MG3 study of nipocalimab in gMG, which was included in the U.S. Biologics License Application  for nipocalimab:. Data evaluating nipocalimab using the clinician-administered QMGa assessment score demonstrat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/nipocalimab-data-real-world-research-120300965.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nipocalimab-data-real-world-research-120300965.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1914381329.SGD","IE00B7SZLL34.SGD","IE00BMQBXF63.USD","MG","LU1162221912.USD","LU0912757837.SGD","LU1221951046.USD","LU1244550494.USD","LU2129689514.USD","LU2505996681.GBP","PT","BK4568","LU1066053197.SGD","IE00BFTCPJ56.SGD","JNJ","LU1066051498.USD","LU0466842654.USD","LU2592432038.USD","IE00BZ18W340.USD","IE00BMG7P694.USD","IE00BSNM7G36.USD","LU2112291526.USD","LU0795875169.SGD","LU0289739699.SGD","LU0345770308.USD","LU2347655156.SGD","IE00BGHQF631.EUR","IE00B19Z4B17.USD","IE00B7SZL793.SGD","BK4581","IE00BMG7P819.SGD","IE00BVYPNW00.USD","LU0320765646.SGD","LU1929549753.HKD","IE00B3PB1722.GBP","LU1894683264.USD","BK4534","OCS","IE00BJJMRZ35.SGD","LU1935042991.SGD","AAN","LU2129689605.HKD","LU0203345920.USD","LU1506573853.SGD","LU1244550221.USD","LU1066051811.HKD","D","LU0345770993.USD","LU2129689431.USD","IE00B42XCP33.USD"],"gpt_icon":0},{"id":"2522274588","title":"Brazil Potash Announces Participation In Diversibram 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522274588","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522274588?lang=en_us&edition=fundamental","pubTime":"2025-03-26 18:45","pubTimestamp":1742985900,"startTime":"0","endTime":"0","summary":" Event promotes diversity, equity, and inclusion in Brazil's mining sector  Company President to serve as event patron and moderator MANAUS, Brazil, March  26, 2025  (GLOBE NEWSWIRE) -- Brazil Potash ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/26/3049458/0/en/Brazil-Potash-Announces-Participation-In-Diversibram-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0541501648.USD","LU1868837565.USD","LU1267930813.SGD","IE00BQXX3F31.USD","LU2089283258.USD","IE0004091025.USD","LU1917777945.USD","BK4612","IE00B3M56506.USD","BK4602","LU0264606111.USD","LU1868838027.USD","LU2237443382.USD","LU2294711713.HKD","LU2750360641.GBP","IE00B66KJ199.SGD","LU1974910355.USD","SG9999000418.SGD","IE0031619046.USD","LU2491050071.SGD","LU1989772840.SGD","LU2106854487.HKD","LU2663582299.SGD","LU0384037296.USD","IE00B7SZL793.SGD","LU2211815571.USD","LU0488056044.USD","LU0792757196.USD","BK4505","BK4605","LU1211504680.USD","LU0889566641.SGD","MG","LU0124676726.USD","BK4527","LU1282649810.SGD","LU2250418816.HKD","BK4533","LU2458330169.SGD","IE00B5TLWC47.USD","LU0878005551.USD","BK4591","LU0353189763.USD","GRO","LU1282649067.USD","LU2458330243.SGD","SGXZ51526630.SGD","LU0882747503.HKD","03145"],"gpt_icon":1},{"id":"2522079582","title":"FDA Accepts Sanofi's Filing for Multiple Sclerosis Drug Tolebrutinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2522079582","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522079582?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:56","pubTimestamp":1742903760,"startTime":"0","endTime":"0","summary":"Sanofi SNY announced that the FDA has accepted its regulatory filing seeking approval for its investigational BTK inhibitor tolebrutinib to treat non-relapsing secondary progressive multiple sclerosis  and slow disability accumulation independent of relapse activity in adults.The filing has been granted priority review by the FDA, bringing down the review period by four months. A final decision is expected by Sept. 28, 2025.The FDA filing is supported by data from three late-stage studies — one  in nrSPMS and two  in relapsing MS . Data from these studies showed that patients treated with tolebrutinib delayed the time to onset of six-month confirmed disability progression when compared to placebo. A similar regulatory filing for the drug is currently under review by the EMA, which is also supported by data from these studies.Per Sanofi, the above results make tolebrutinib the first and the only brain-penetrant BTK inhibitor to treat both the above MS indications. If approved, tolebruti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-accepts-sanofis-filing-multiple-115600487.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2357305700.SGD","LU1074936037.SGD","ETNB","BK4139","BK4504","BK4588","LU0098860793.USD","BK4581","LU0158827948.USD","MG","LU1720051017.SGD","CTMX","LU1668664300.SGD","LU2089283258.USD","LU0795875169.SGD","BK4534","IE00B19Z4B17.USD","LU1989772840.SGD","IE00B66KJ199.SGD","LU2023251221.USD","LU2028103732.USD","LU2111349929.HKD","ANIP","LU0267386448.USD","SNY","IE00BZ1G4Q59.USD","LU0912757837.SGD","LU0971096721.USD","LU1732800096.USD","LU0225283273.USD","IE00BFXG1179.USD","IE00BKVL7J92.USD","LU0320765646.SGD","LU1548497426.USD","IE0031619046.USD","LU1162221912.USD","SNYNF","BK4123","LU2271345857.HKD","BK4585","LU0158827781.USD","LU2133065610.SGD","LU0314104364.USD","LU1732799900.SGD","LU1720051108.HKD","LU0106261372.USD","LU0106831901.USD","LU1363072403.SGD","BK4516"],"gpt_icon":0},{"id":"2521461815","title":"IMVT Unlikely to Pursue Batoclimab for MG & CIDP Despite Success","url":"https://stock-news.laohu8.com/highlight/detail?id=2521461815","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521461815?lang=en_us&edition=fundamental","pubTime":"2025-03-20 22:19","pubTimestamp":1742480340,"startTime":"0","endTime":"0","summary":"Immunovant IMVT announced top-line data from a late-stage study of its investigational candidate, batoclimab, for myasthenia gravis  and initial results from Period 1 of a mid-stage study of the same candidate for chronic inflammatory demyelinating polyneuropathy .IMVT’s Batoclimab Shows Superior Efficacy in MG Patients. The phase III study is evaluating the efficacy and safety of batoclimab in adult patients with moderate to severe MG. Per the data readout, the study met its primary endpoint of mean change from baseline in the MG Activities of Daily Living  score, used to determine the impact of weekly or bi-monthly doses of batoclimab, in acetylcholine receptor antibody positive  patients after 12 weeks.Immunovant reported that MG patients who received the weekly680mg subcutaneous dose of batoclimab achieved a 5.6-point improvement in MG-ADL and a 4.7-point improvement was observed in patients receiving the 340mg dose compared to a 3.6-point improvement in the placebo group at week 1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/imvt-unlikely-pursue-batoclimab-mg-141900033.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2087621335.USD","IE0002270589.USD","LU1430594728.SGD","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0234570918.USD","LU0320765992.SGD","LU1066051498.USD","BK4007","IE00B66KJ199.SGD","BK4566","LU0109394709.USD","IE0031619046.USD","BK4532","LU1839511570.USD","LU2468319806.SGD","BK4123","BK4588","IE00B19Z3B42.SGD","IE00B19Z4B17.USD","IE00B7SZL793.SGD","IMVT","BK4578","IE00B3T34201.USD","ARVN","BK4583","BK4585","IE00B7SZLL34.SGD","LU0889565916.HKD","LU2089984988.USD","DVAX","MG","LU1571399168.USD","IE00B19Z3581.USD","LU0289739699.SGD","GILD","BK4568","BK4139","LU0058720904.USD","LU1585245621.USD","BK4550","LU1066053197.SGD"],"gpt_icon":0},{"id":"2520578321","title":"Immunovant Ditches Seeking FDA Approval For Batoclimab For Two Autoimmune Disorders Despite Positive Phase 3 Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2520578321","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520578321?lang=en_us&edition=fundamental","pubTime":"2025-03-20 00:39","pubTimestamp":1742402340,"startTime":"0","endTime":"0","summary":"Wednesday, Immunovant,Inc.  released topline results from its Phase 3 study of batoclimab in myasthenia gravis  and initial results from Period 1 of its Phase 2b study in chronic inflammatory demyelinating polyneuropathy .Immunovant is a member of theRoivant Sciences Ltd. family of companies.In the Phase 3 MG study, batoclimab met its primary endpoint of mean change from baseline in Myasthenia Gravis Activities of Daily Living  score in acetylcholine receptor antibody positive  participants.Participants entering the study and randomized to 680mg of batoclimab given weekly by subcutaneous injection achieved a 5.6-point improvement  in MG-ADL at Week 12.In comparison, those randomized to 340mg of batoclimab given weekly by subcutaneous injection achieved a 4.7-point improvement .Initial batoclimab data in 73 patients pooled across all cohorts for the run-in Period 1 of the Phase 2b CIDP study demonstrated a 1.8 point improvement in aINCAT  at Week 12.An 84% responder rate  was observed a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/immunovant-ditches-seeking-fda-approval-163900373.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4123","IE00B7SZL793.SGD","IE00B19Z4B17.USD","ROIV","IE00B66KJ199.SGD","BK4139","BK4588","IE0031619046.USD","MG","BK4007","IMVT"],"gpt_icon":0},{"id":"2520157679","title":"Immunovant’s Batoclimab Shows Promising Efficacy in MG and CIDP, Justifying Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2520157679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520157679?lang=en_us&edition=fundamental","pubTime":"2025-03-20 00:35","pubTimestamp":1742402111,"startTime":"0","endTime":"0","summary":"Douglas Tsao, an analyst from H.C. Wainwright, reiterated the Buy rating on Immunovant (IMVT – Research Report). The associated price target remain...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/immunovants-batoclimab-shows-promising-efficacy-in-mg-and-cidp-justifying-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/immunovants-batoclimab-shows-promising-efficacy-in-mg-and-cidp-justifying-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MG"],"gpt_icon":0},{"id":"2520157655","title":"Immunovant’s batoclimab shows ‘impressive’ efficacy in MG, says H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2520157655","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520157655?lang=en_us&edition=fundamental","pubTime":"2025-03-20 00:30","pubTimestamp":1742401847,"startTime":"0","endTime":"0","summary":"Immunovant (IMVT) reported best absolute improvements with IMVT-1402 in myasthenia gravis and chronic inflammatory demyelinating polyneuropathy, an...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immunovants-batoclimab-shows-impressive-efficacy-in-mg-says-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immunovants-batoclimab-shows-impressive-efficacy-in-mg-says-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MG","BK4588","BK4123","BK4139","BK4585","IMVT","IE00B7SZL793.SGD","IE00B66KJ199.SGD","IE0031619046.USD","IE00B19Z4B17.USD"],"gpt_icon":0},{"id":"2520183241","title":"Roivant says Immunovant announces results from Phase 3 study of batoclimab in MG","url":"https://stock-news.laohu8.com/highlight/detail?id=2520183241","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520183241?lang=en_us&edition=fundamental","pubTime":"2025-03-19 19:55","pubTimestamp":1742385322,"startTime":"0","endTime":"0","summary":"Immunovant (IMVT) reported topline results from its Phase 3 study of batoclimab in MG and initial results from Period 1 of its Phase 2b study in CI...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roivant-says-immunovant-announces-results-from-phase-3-study-of-batoclimab-in-mg?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roivant-says-immunovant-announces-results-from-phase-3-study-of-batoclimab-in-mg?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IE00B7SZL793.SGD","BK4588","IE00B19Z4B17.USD","IE00B66KJ199.SGD","MG","IMVT","IE0031619046.USD","BK4123","BK4585"],"gpt_icon":0},{"id":"2520986932","title":"Roivant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2520986932","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520986932?lang=en_us&edition=fundamental","pubTime":"2025-03-19 04:32","pubTimestamp":1742329920,"startTime":"0","endTime":"0","summary":"NEW YORK, March  18, 2025  (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today announ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/18/3045004/34323/en/Roivant-to-Host-Investor-Webcast-at-8-00-AM-ET-on-Wednesday-March-19-to-Review-Results-from-Batoclimab-Myasthenia-Gravis-MG-and-Chronic-Inflammatory-Demyelinating-Polyneuropathy-CI.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZL793.SGD","BK4144","BK4585","BK4581","BK4561","IE0031619046.USD","IE00B66KJ199.SGD","BK4590","BK4123","AM","BK4181","MG","ET","BK4218","HST","BK4588","IE00B19Z4B17.USD"],"gpt_icon":0},{"id":"2520932988","title":"Immunovant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2520932988","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520932988?lang=en_us&edition=fundamental","pubTime":"2025-03-19 04:32","pubTimestamp":1742329920,"startTime":"0","endTime":"0","summary":"NEW YORK, March  18, 2025  (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today announ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/18/3045005/0/en/Immunovant-to-Host-Investor-Webcast-at-8-00-AM-ET-on-Wednesday-March-19-to-Review-Results-from-Batoclimab-Myasthenia-Gravis-MG-and-Chronic-Inflammatory-Demyelinating-Polyneuropathy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZL793.SGD","BK4181","BK4585","BK4588","BK4590","BK4123","BK4144","HST","IE00B66KJ199.SGD","IE0031619046.USD","BK4561","BK4218","ET","AM","MG","BK4581","IE00B19Z4B17.USD"],"gpt_icon":0},{"id":"2520548599","title":"Is Now The Time To Look At Buying Magna International Inc. (TSE:MG)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520548599","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520548599?lang=en_us&edition=fundamental","pubTime":"2025-03-17 18:00","pubTimestamp":1742205609,"startTime":"0","endTime":"0","summary":"Magna International Inc.  received a lot of attention from a substantial price movement on the TSX over the last few months, increasing to CA$64.94 at one point, and dropping to the lows of CA$49.45. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Magna International's current trading price of CA$52.31 reflective of the actual value of the large-cap?Or is it currently undervalued, providing us with the opportunity to buy?Let’s take a look at Magna International’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.If you’ve been keeping an eye on MG for a while, now might be the time to enter the stock. Its prosperous future profit outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy MG. But before you make any investment decisions, consider ot","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/now-time-look-buying-magna-100009311.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B19Z4B17.USD","MG","IE0031619046.USD","BK4123","BK4511","MGA","IE00B66KJ199.SGD","TSE","IE00B7SZL793.SGD","BK4124","BK4090"],"gpt_icon":0},{"id":"2520551301","title":"Market Chatter: Meritz Financial Group Subsidiary Drops MG Non-Life Acquisition Amid Union Opposition","url":"https://stock-news.laohu8.com/highlight/detail?id=2520551301","media":"MT Newswires Live","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520551301?lang=en_us&edition=fundamental","pubTime":"2025-03-17 11:26","pubTimestamp":1742182000,"startTime":"0","endTime":"0","summary":"Meritz Financial Group  subsidiary Meritz Fire & Marine Insurance abandoned its bid to acquire MG Non-Life Insurance, citing opposition from the latter's labor union, Pulse News reported Friday.The Korea Deposit Insurance Corp.  selected Meritz Fire & Marine Insurance as the preferred bidder but Meritz withdrew due to unresolved disputes. Following Meritz Fire & Marine Insurance's exit, regulators, including the Financial Services Commission and the Financial Supervisory Service, raised concerns over MG Non-Life's viability, the report said.With previous failed attempts to sell MG Non-Life Insurance and over 10,000 policyholders at risk, KDIC plans to seek another buyer. However, prospects for the same remain uncertain, it said.Shares of Meritz Financial Group rose more than 1% in recent trade on Monday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MG","IE0031619046.USD","BK4123","IE00B66KJ199.SGD","IE00B7SZL793.SGD","IE00B19Z4B17.USD"],"gpt_icon":0},{"id":"2517175835","title":"MISTRAS Group Inc (MG) Q4 2024 Earnings Call Highlights: Record Operating Income and Strategic ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2517175835","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517175835?lang=en_us&edition=fundamental","pubTime":"2025-03-07 15:09","pubTimestamp":1741331381,"startTime":"0","endTime":"0","summary":"Full Year Revenue: $729.6 million, a 3.4% increase over 2023.Adjusted EBITDA: $82.5 million, up 25.3% from the prior year.Operating Income: $39.8 million for the full year 2024, highest since 2016.Net Income: $19 million or $0.60 per diluted share for the year ended December 31, 2024.Free Cash Flow: $27.1 million for full year 2024, compared to $3.1 million in the prior year.Gross Profit Margin: Increased to 29.2%, up 30 basis points from the prior year.SG&A Expenses: $156.4 million, down 6.2% from 2023.Interest Expense: $3.9 million for the fourth quarter, down from $4.7 million in the prior year quarter.Effective Income Tax Rate: 21.8% for the full year 2024.Gross Debt: $169.6 million as of December 31, 2024, a decrease of $20.8 million from the prior year.International Segment Revenue: $35 million in Q4 2024, up 3.6% from the prior year.Products and Systems Segment Revenue: $13.7 million in 2024, a 5.2% increase from 2023.GuruFocus has detected 5 Warning Signs with NNBR.MISTRAS Grou","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mistras-group-inc-mg-q4-070941231.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MG"],"gpt_icon":0},{"id":"2517541124","title":"Q4 2024 Mistras Group Inc Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2517541124","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517541124?lang=en_us&edition=fundamental","pubTime":"2025-03-07 13:34","pubTimestamp":1741325667,"startTime":"0","endTime":"0","summary":"Manuel Stamatakis; Chairman of the Board, Interim President, Chief Executive Officer; Mistras Group Inc. Natalia Shuman-Fabbri; President, Chief Executive Officer, Director; Mistras Group Inc. Edward Prajzner; Chief Financial Officer, Senior Executive Vice President; Mistras Group Inc. Thank you for joining Mistress Group's conference call for its fourth quarter and fiscal year ending December 30, 2024. My name is Tanya, and I'll be your event manager today. We'll be accepting questions after management's prepared remarks. I would now like to turn the call over to Tommy Tobolski, Treasurer, your line is open.Thanks Tommy. Good morning, everyone. Thank you for joining us today. Before we commence today's conference call, I want to take a minute to reflect on the life of Dr. Sotirios Vahaviolos the company's Founder, Chairman Emeritus, and Board Director. Sotirius passed away nearly one month ago on February 6, 2025. On behalf of the Board of Directors and the entire Mistress family, I w","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-2024-mistras-group-inc-053427325.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MG"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":97,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-07","symbol":"MG","fiscalQuarterEnding":"2025/03","expectedEps":0.16,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":-0.01},{"market":"US","date":"2025-03-05","symbol":"MG","fiscalQuarterEnding":"2024/12","expectedEps":0.13,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741150800000,"reportTimeType":"post","actualEps":0.24},{"market":"US","date":"2024-10-30","symbol":"MG","fiscalQuarterEnding":"2024/09","expectedEps":0.26,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730260800000,"reportTimeType":"post","actualEps":0.2},{"market":"US","date":"2024-07-31","symbol":"MG","fiscalQuarterEnding":"2024/06","expectedEps":0.15,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722398400000,"reportTimeType":"post","actualEps":0.21},{"market":"US","date":"2024-05-01","symbol":"MG","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1714536000000,"reportTimeType":"post","actualEps":0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1714708800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MG","date":"2025-05-12","current":16.579762,"percent":0.474958,"low":-70.097801,"twenty":-16.730743,"median":24.705841,"eighty":51.799126,"high":138.054755,"avg":19.633874,"sd":43.73858,"marketCap":244999145},"quantilePoints":[{"date":"2020-05-15","current":17.200288,"twenty":24.003609,"median":30.834383,"eighty":55.46796,"marketCap":104233747},{"date":"2020-05-22","current":-1.384386,"twenty":21.196122,"median":30.762256,"eighty":55.46796,"marketCap":120657556},{"date":"2020-05-29","current":-1.347692,"twenty":20.321199,"median":30.726192,"eighty":55.46796,"marketCap":117459404},{"date":"2020-06-05","current":-1.848072,"twenty":19.047365,"median":30.631004,"eighty":55.46796,"marketCap":161070569},{"date":"2020-06-12","current":-1.601218,"twenty":18.559107,"median":30.583036,"eighty":55.46796,"marketCap":139555728},{"date":"2020-06-19","current":-1.484462,"twenty":17.816272,"median":30.553181,"eighty":55.46796,"marketCap":129379789},{"date":"2020-06-26","current":-1.157547,"twenty":17.196322,"median":30.537616,"eighty":55.46796,"marketCap":100887161},{"date":"2020-07-02","current":-1.184234,"twenty":16.404955,"median":30.5126,"eighty":55.46796,"marketCap":103213090},{"date":"2020-07-10","current":-1.160883,"twenty":15.456075,"median":30.4131,"eighty":55.46796,"marketCap":101177902},{"date":"2020-07-17","current":-1.200913,"twenty":-1.134196,"median":30.37173,"eighty":55.46796,"marketCap":104666796},{"date":"2020-07-24","current":-1.167555,"twenty":-1.163552,"median":30.312,"eighty":55.46796,"marketCap":101759385},{"date":"2020-07-31","current":-1.177562,"twenty":-1.184234,"median":30.273019,"eighty":55.46796,"marketCap":102631608},{"date":"2020-08-07","current":-1.236344,"twenty":-1.194242,"median":30.221302,"eighty":55.46796,"marketCap":120225795},{"date":"2020-08-14","current":-1.31717,"twenty":-1.224264,"median":30.197259,"eighty":55.46796,"marketCap":128085592},{"date":"2020-08-21","current":-1.386022,"twenty":-1.265216,"median":30.146336,"eighty":55.46796,"marketCap":134780976},{"date":"2020-08-28","current":-1.415958,"twenty":-1.289157,"median":30.089068,"eighty":55.46796,"marketCap":137692012},{"date":"2020-09-04","current":-1.338125,"twenty":-1.31717,"median":30.061814,"eighty":55.46796,"marketCap":130123318},{"date":"2020-09-11","current":-1.173479,"twenty":-1.31717,"median":30.053005,"eighty":55.46796,"marketCap":114112619},{"date":"2020-09-18","current":-1.269273,"twenty":-1.31717,"median":29.992899,"eighty":55.46796,"marketCap":123427934},{"date":"2020-09-25","current":-1.19144,"twenty":-1.31717,"median":29.962968,"eighty":55.46796,"marketCap":115859240},{"date":"2020-10-02","current":-1.188447,"twenty":-1.31717,"median":29.949117,"eighty":55.46796,"marketCap":115568137},{"date":"2020-10-09","current":-1.215389,"twenty":-1.31717,"median":29.904952,"eighty":55.46796,"marketCap":118188069},{"date":"2020-10-16","current":-1.164498,"twenty":-1.31717,"median":29.89529,"eighty":55.46796,"marketCap":113239308},{"date":"2020-10-23","current":-1.179466,"twenty":-1.31717,"median":29.89529,"eighty":55.46796,"marketCap":114694826},{"date":"2020-10-30","current":-1.113608,"twenty":-1.31717,"median":29.883445,"eighty":55.46796,"marketCap":108290546},{"date":"2020-11-06","current":-1.184684,"twenty":-1.31717,"median":29.829957,"eighty":55.46796,"marketCap":117062173},{"date":"2020-11-13","current":-1.299903,"twenty":-1.334034,"median":29.812581,"eighty":55.46796,"marketCap":128447272},{"date":"2020-11-20","current":-1.453527,"twenty":-1.37764,"median":29.751898,"eighty":55.46796,"marketCap":143627405},{"date":"2020-11-27","current":-1.710554,"twenty":-1.392757,"median":29.728432,"eighty":55.46796,"marketCap":169024933},{"date":"2020-12-04","current":-1.734188,"twenty":-1.432123,"median":29.674002,"eighty":55.46796,"marketCap":171360338},{"date":"2020-12-11","current":-2.035529,"twenty":-1.449637,"median":29.643481,"eighty":55.46796,"marketCap":201136752},{"date":"2020-12-18","current":-2.22756,"twenty":-1.464447,"median":29.615582,"eighty":55.46796,"marketCap":220111917},{"date":"2020-12-24","current":-2.260058,"twenty":-1.474406,"median":29.608495,"eighty":55.46796,"marketCap":223323099},{"date":"2020-12-31","current":-2.292555,"twenty":-1.487131,"median":29.572157,"eighty":55.46796,"marketCap":226534281},{"date":"2021-01-08","current":-2.378231,"twenty":-1.546884,"median":29.552191,"eighty":55.46796,"marketCap":235000124},{"date":"2021-01-15","current":-2.449135,"twenty":-1.600632,"median":29.512051,"eighty":55.46796,"marketCap":242006338},{"date":"2021-01-22","current":-2.508221,"twenty":-1.645918,"median":29.49579,"eighty":55.46796,"marketCap":247844851},{"date":"2021-01-29","current":-2.041438,"twenty":-1.808046,"median":29.45607,"eighty":55.46796,"marketCap":201720603},{"date":"2021-02-05","current":-2.248241,"twenty":-1.970422,"median":29.415881,"eighty":55.46796,"marketCap":222155396},{"date":"2021-02-12","current":-2.339825,"twenty":-2.082798,"median":29.375511,"eighty":55.46796,"marketCap":231205091},{"date":"2021-02-19","current":-2.277784,"twenty":-2.144248,"median":29.336597,"eighty":55.46796,"marketCap":225074653},{"date":"2021-02-26","current":-2.351642,"twenty":-2.182654,"median":29.283648,"eighty":55.46796,"marketCap":232372793},{"date":"2021-03-05","current":-2.871603,"twenty":-2.245286,"median":29.236448,"eighty":55.487531,"marketCap":283751702},{"date":"2021-03-12","current":-3.172944,"twenty":-2.274239,"median":29.132067,"eighty":55.46796,"marketCap":313528115},{"date":"2021-03-19","current":-3.350753,"twenty":-2.312645,"median":29.091309,"eighty":55.46796,"marketCap":333269230},{"date":"2021-03-26","current":-3.230243,"twenty":-2.345143,"median":29.036446,"eighty":55.448388,"marketCap":321283231},{"date":"2021-04-01","current":-3.438931,"twenty":-2.377049,"median":29.004385,"eighty":55.448388,"marketCap":342039473},{"date":"2021-04-09","current":-3.291968,"twenty":-2.444999,"median":28.977109,"eighty":55.46796,"marketCap":327422401},{"date":"2021-04-16","current":-3.322437,"twenty":-2.498767,"median":28.95901,"eighty":55.46796,"marketCap":330452899},{"date":"2021-04-23","current":-3.25758,"twenty":-2.572034,"median":28.917102,"eighty":55.46796,"marketCap":324002177},{"date":"2021-04-30","current":-3.281164,"twenty":-2.843832,"median":28.855483,"eighty":55.46796,"marketCap":326347894},{"date":"2021-05-07","current":-50.575904,"twenty":-3.0533,"median":28.852218,"eighty":55.46796,"marketCap":319336256},{"date":"2021-05-14","current":-49.317333,"twenty":-3.147438,"median":28.852218,"eighty":55.46796,"marketCap":311389639},{"date":"2021-05-21","current":-47.499397,"twenty":-3.181983,"median":28.850885,"eighty":55.46796,"marketCap":299911193},{"date":"2021-05-28","current":-48.524899,"twenty":-3.228046,"median":28.819314,"eighty":55.46796,"marketCap":306386214},{"date":"2021-06-04","current":-49.736856,"twenty":-3.257403,"median":28.777405,"eighty":55.46796,"marketCap":314038511},{"date":"2021-06-11","current":-52.673522,"twenty":-3.318107,"median":28.698266,"eighty":55.46796,"marketCap":332580616},{"date":"2021-06-18","current":-46.940032,"twenty":-3.37603,"median":28.667194,"eighty":55.46796,"marketCap":296379363},{"date":"2021-06-25","current":-47.825693,"twenty":-3.474202,"median":28.568584,"eighty":55.46796,"marketCap":301971427},{"date":"2021-07-02","current":-45.728075,"twenty":-45.392456,"median":28.554497,"eighty":55.46796,"marketCap":288727066},{"date":"2021-07-09","current":-45.867916,"twenty":-45.662816,"median":28.504767,"eighty":55.46796,"marketCap":289610023},{"date":"2021-07-16","current":-45.308551,"twenty":-45.802657,"median":28.436782,"eighty":55.46796,"marketCap":286078194},{"date":"2021-07-23","current":-46.986646,"twenty":-46.529831,"median":28.38383,"eighty":55.46796,"marketCap":296673683},{"date":"2021-07-30","current":-48.944423,"twenty":-46.977323,"median":28.253624,"eighty":55.46796,"marketCap":309035086},{"date":"2021-08-06","current":133.405577,"twenty":-46.977323,"median":28.253624,"eighty":55.874346,"marketCap":304031310},{"date":"2021-08-13","current":125.398659,"twenty":-46.977323,"median":28.262894,"eighty":56.431086,"marketCap":285783545},{"date":"2021-08-20","current":125.140372,"twenty":-46.977323,"median":28.262894,"eighty":56.640736,"marketCap":285194907},{"date":"2021-08-27","current":129.143831,"twenty":-46.977323,"median":28.262894,"eighty":57.107133,"marketCap":294318790},{"date":"2021-09-03","current":126.173522,"twenty":-46.977323,"median":28.262894,"eighty":57.425347,"marketCap":287549457},{"date":"2021-09-10","current":118.295749,"twenty":-46.977323,"median":28.262894,"eighty":57.64318,"marketCap":269596011},{"date":"2021-09-17","current":118.295749,"twenty":-46.977323,"median":28.262894,"eighty":58.186658,"marketCap":269596011},{"date":"2021-09-24","current":126.044379,"twenty":-46.977323,"median":28.262894,"eighty":58.365972,"marketCap":287255139},{"date":"2021-10-01","current":133.276433,"twenty":-46.977323,"median":28.355472,"eighty":58.779088,"marketCap":303736991},{"date":"2021-10-08","current":125.656947,"twenty":-46.977323,"median":28.49725,"eighty":65.374215,"marketCap":286372182},{"date":"2021-10-15","current":124.623796,"twenty":-46.977323,"median":28.588837,"eighty":69.299134,"marketCap":284017632},{"date":"2021-10-22","current":123.978077,"twenty":-46.977323,"median":28.735497,"eighty":73.667601,"marketCap":282546038},{"date":"2021-10-29","current":126.819241,"twenty":-46.977323,"median":28.819314,"eighty":78.147012,"marketCap":289021051},{"date":"2021-11-05","current":67.306672,"twenty":-46.977323,"median":28.875193,"eighty":80.685826,"marketCap":278380396},{"date":"2021-11-12","current":65.169952,"twenty":-46.977323,"median":28.945041,"eighty":80.685826,"marketCap":269542923},{"date":"2021-11-19","current":63.175681,"twenty":-46.977323,"median":28.977109,"eighty":80.685826,"marketCap":261294615},{"date":"2021-11-26","current":58.047553,"twenty":-46.977323,"median":29.028858,"eighty":80.685826,"marketCap":240084680},{"date":"2021-12-03","current":56.979193,"twenty":-46.977323,"median":29.112676,"eighty":80.685826,"marketCap":235665944},{"date":"2021-12-10","current":56.053281,"twenty":-46.977323,"median":29.196494,"eighty":80.685826,"marketCap":231836372},{"date":"2021-12-17","current":54.343906,"twenty":-46.977323,"median":29.196494,"eighty":80.685826,"marketCap":224766394},{"date":"2021-12-23","current":53.133098,"twenty":-46.977323,"median":29.196494,"eighty":80.685826,"marketCap":219758492},{"date":"2021-12-31","current":52.919426,"twenty":-46.977323,"median":29.196494,"eighty":80.685826,"marketCap":218874745},{"date":"2022-01-07","current":54.130234,"twenty":-46.968,"median":29.236448,"eighty":80.242988,"marketCap":223882646},{"date":"2022-01-14","current":51.067602,"twenty":-46.958678,"median":29.24867,"eighty":79.80015,"marketCap":211215602},{"date":"2022-01-21","current":49.999242,"twenty":-46.958678,"median":29.24867,"eighty":79.80015,"marketCap":206796865},{"date":"2022-01-28","current":48.503538,"twenty":-46.949355,"median":29.250521,"eighty":79.357312,"marketCap":200610634},{"date":"2022-02-04","current":47.29273,"twenty":-46.949355,"median":29.250521,"eighty":79.357312,"marketCap":195602733},{"date":"2022-02-11","current":47.221507,"twenty":-46.949355,"median":29.250521,"eighty":79.357312,"marketCap":195308151},{"date":"2022-02-18","current":47.506402,"twenty":-46.949355,"median":29.250521,"eighty":79.357312,"marketCap":196486480},{"date":"2022-02-25","current":48.076194,"twenty":-46.949355,"median":29.250521,"eighty":79.357312,"marketCap":198843140},{"date":"2022-03-04","current":45.512131,"twenty":-46.949355,"median":29.250521,"eighty":79.357312,"marketCap":188238172},{"date":"2022-03-11","current":50.136793,"twenty":-46.949355,"median":29.250521,"eighty":79.357312,"marketCap":193528022},{"date":"2022-03-18","current":53.657033,"twenty":-46.949355,"median":29.269699,"eighty":79.357312,"marketCap":207116149},{"date":"2022-03-25","current":46.9212,"twenty":-46.949355,"median":29.338396,"eighty":79.357312,"marketCap":181115833},{"date":"2022-04-01","current":50.978009,"twenty":-46.949355,"median":29.345177,"eighty":79.357312,"marketCap":196775114},{"date":"2022-04-08","current":46.768113,"twenty":-46.949355,"median":29.399054,"eighty":79.357312,"marketCap":180524917},{"date":"2022-04-14","current":46.385395,"twenty":-46.949355,"median":29.452008,"eighty":79.357312,"marketCap":179047626},{"date":"2022-04-22","current":46.768113,"twenty":-46.949355,"median":29.458993,"eighty":79.357312,"marketCap":180524917},{"date":"2022-04-29","current":43.553284,"twenty":-46.949355,"median":29.458993,"eighty":79.357312,"marketCap":168115675},{"date":"2022-05-06","current":43.020371,"twenty":-46.949355,"median":29.458993,"eighty":79.357312,"marketCap":166015610},{"date":"2022-05-13","current":41.707361,"twenty":-46.949355,"median":29.458993,"eighty":79.357312,"marketCap":160948706},{"date":"2022-05-20","current":41.243946,"twenty":-46.949355,"median":29.458993,"eighty":79.357312,"marketCap":159160387},{"date":"2022-05-27","current":45.414682,"twenty":-46.949355,"median":29.486991,"eighty":79.357312,"marketCap":175255258},{"date":"2022-06-03","current":44.024437,"twenty":-46.949355,"median":29.564353,"eighty":79.357312,"marketCap":169890301},{"date":"2022-06-10","current":51.207371,"twenty":-46.949355,"median":29.612039,"eighty":79.357312,"marketCap":197609245},{"date":"2022-06-17","current":46.418748,"twenty":-46.949355,"median":29.612039,"eighty":79.357312,"marketCap":179129949},{"date":"2022-06-24","current":48.735824,"twenty":-46.958678,"median":29.608495,"eighty":79.80015,"marketCap":188071543},{"date":"2022-07-01","current":47.808994,"twenty":-46.958678,"median":29.608495,"eighty":79.80015,"marketCap":184494906},{"date":"2022-07-08","current":45.878097,"twenty":-46.958678,"median":29.608495,"eighty":79.80015,"marketCap":177043577},{"date":"2022-07-15","current":46.57322,"twenty":-46.958678,"median":29.608495,"eighty":79.80015,"marketCap":179726055},{"date":"2022-07-22","current":47.963465,"twenty":-46.958678,"median":29.608495,"eighty":79.80015,"marketCap":185091012},{"date":"2022-07-29","current":47.654522,"twenty":-46.958678,"median":29.643481,"eighty":79.80015,"marketCap":183898799},{"date":"2022-08-05","current":76.928635,"twenty":-46.958678,"median":29.89529,"eighty":79.80015,"marketCap":197321949},{"date":"2022-08-12","current":77.044841,"twenty":-46.958678,"median":31.126355,"eighty":79.80015,"marketCap":197620018},{"date":"2022-08-19","current":66.818678,"twenty":-46.958678,"median":31.210291,"eighty":79.80015,"marketCap":171389910},{"date":"2022-08-26","current":64.726963,"twenty":-46.958678,"median":31.4621,"eighty":79.80015,"marketCap":166024661},{"date":"2022-09-02","current":62.867661,"twenty":-46.958678,"median":31.825824,"eighty":79.80015,"marketCap":161255550},{"date":"2022-09-09","current":58.916643,"twenty":-46.958678,"median":31.963297,"eighty":79.80015,"marketCap":151121190},{"date":"2022-09-16","current":55.430451,"twenty":-46.958678,"median":32.105611,"eighty":79.80015,"marketCap":142179108},{"date":"2022-09-23","current":56.011483,"twenty":-46.958678,"median":32.833058,"eighty":79.80015,"marketCap":143669455},{"date":"2022-09-30","current":51.828053,"twenty":-46.958678,"median":41.16671,"eighty":79.80015,"marketCap":132938956},{"date":"2022-10-07","current":55.662864,"twenty":-46.958678,"median":41.707361,"eighty":79.80015,"marketCap":142775247},{"date":"2022-10-14","current":51.247021,"twenty":-46.958678,"median":42.170776,"eighty":79.80015,"marketCap":131448609},{"date":"2022-10-21","current":56.708722,"twenty":-46.958678,"median":44.024437,"eighty":79.80015,"marketCap":145457872},{"date":"2022-10-28","current":55.546658,"twenty":-46.958678,"median":44.318719,"eighty":79.80015,"marketCap":142477177},{"date":"2022-11-04","current":37.74346,"twenty":-46.958678,"median":44.438185,"eighty":79.80015,"marketCap":134291232},{"date":"2022-11-11","current":35.793922,"twenty":-46.958678,"median":44.438185,"eighty":79.80015,"marketCap":127354774},{"date":"2022-11-18","current":34.617596,"twenty":-46.958678,"median":44.438185,"eighty":79.80015,"marketCap":123169406},{"date":"2022-11-25","current":33.945409,"twenty":-46.958678,"median":44.438185,"eighty":79.80015,"marketCap":120777767},{"date":"2022-12-02","current":32.769083,"twenty":-46.958678,"median":44.438185,"eighty":79.80015,"marketCap":116592399},{"date":"2022-12-09","current":35.709899,"twenty":-46.958678,"median":44.438185,"eighty":79.80015,"marketCap":127055819},{"date":"2022-12-16","current":43.019925,"twenty":-46.958678,"median":44.438185,"eighty":79.80015,"marketCap":153064893},{"date":"2022-12-23","current":43.019925,"twenty":-46.958678,"median":44.438185,"eighty":79.80015,"marketCap":153064893},{"date":"2022-12-30","current":41.423482,"twenty":-46.958678,"median":44.438185,"eighty":79.80015,"marketCap":147384750},{"date":"2023-01-06","current":42.095669,"twenty":-46.585768,"median":44.438185,"eighty":79.80015,"marketCap":149776389},{"date":"2023-01-13","current":42.347739,"twenty":-45.765366,"median":44.438185,"eighty":79.80015,"marketCap":150673254},{"date":"2023-01-20","current":42.935902,"twenty":-45.327197,"median":44.438185,"eighty":79.80015,"marketCap":152765938},{"date":"2023-01-27","current":43.653879,"twenty":-44.366954,"median":44.438185,"eighty":79.80015,"marketCap":155320502},{"date":"2023-02-03","current":46.177225,"twenty":-3.484249,"median":44.728667,"eighty":79.80015,"marketCap":164298565},{"date":"2023-02-10","current":46.009002,"twenty":-3.378883,"median":45.084787,"eighty":79.80015,"marketCap":163700028},{"date":"2023-02-17","current":46.513671,"twenty":-3.333763,"median":45.439392,"eighty":79.80015,"marketCap":165495640},{"date":"2023-02-24","current":44.158548,"twenty":-3.285486,"median":45.439392,"eighty":79.80015,"marketCap":157116114},{"date":"2023-03-03","current":45.420221,"twenty":-3.234103,"median":45.588444,"eighty":79.80015,"marketCap":161605146},{"date":"2023-03-10","current":25.648979,"twenty":-3.191843,"median":45.588444,"eighty":79.80015,"marketCap":166692716},{"date":"2023-03-17","current":24.774059,"twenty":-3.162635,"median":45.588444,"eighty":79.80015,"marketCap":161006609},{"date":"2023-03-24","current":30.62221,"twenty":-3.057186,"median":45.588444,"eighty":79.80015,"marketCap":199013745},{"date":"2023-03-31","current":31.22084,"twenty":-2.902328,"median":45.550287,"eighty":79.357312,"marketCap":202904239},{"date":"2023-04-06","current":34.16794,"twenty":-2.6713,"median":45.550287,"eighty":79.357312,"marketCap":222057442},{"date":"2023-04-14","current":34.950763,"twenty":-2.523583,"median":45.588444,"eighty":79.80015,"marketCap":227145011},{"date":"2023-04-21","current":36.202989,"twenty":-2.455043,"median":45.588444,"eighty":79.80015,"marketCap":235283224},{"date":"2023-04-28","current":36.249462,"twenty":-2.385912,"median":45.588444,"eighty":79.80015,"marketCap":235585256},{"date":"2023-05-05","current":29.693701,"twenty":-2.34987,"median":45.588444,"eighty":79.80015,"marketCap":204173888},{"date":"2023-05-12","current":30.407751,"twenty":-2.316781,"median":45.630499,"eighty":80.242988,"marketCap":209083696},{"date":"2023-05-17","current":30.055197,"twenty":-2.292555,"median":45.672555,"eighty":81.128664,"marketCap":206659537},{"date":"2023-05-22","current":32.479004,"twenty":-2.280147,"median":45.69809,"eighty":82.321325,"marketCap":223325629},{"date":"2023-06-06","current":31.289135,"twenty":-2.208062,"median":45.878097,"eighty":86.440164,"marketCap":215144093},{"date":"2023-06-30","current":33.712941,"twenty":-2.026075,"median":46.094513,"eighty":90.434191,"marketCap":231810185},{"date":"2023-07-07","current":34.814671,"twenty":-1.896733,"median":46.094513,"eighty":90.434191,"marketCap":239385681},{"date":"2023-07-21","current":34.241772,"twenty":-1.637912,"median":46.155765,"eighty":90.614477,"marketCap":235446423},{"date":"2023-07-28","current":32.919696,"twenty":-1.590954,"median":46.155765,"eighty":90.614477,"marketCap":226355827},{"date":"2023-08-04","current":72.158812,"twenty":-1.529421,"median":46.18704,"eighty":90.780895,"marketCap":185448148},{"date":"2023-08-11","current":64.848606,"twenty":-1.529421,"median":46.18704,"eighty":87.078099,"marketCap":166660917},{"date":"2023-08-18","current":66.381391,"twenty":-1.529421,"median":46.18704,"eighty":77.914166,"marketCap":170600175},{"date":"2023-08-25","current":64.730699,"twenty":-1.529421,"median":46.18704,"eighty":76.115289,"marketCap":166357897},{"date":"2023-09-01","current":62.962101,"twenty":-1.529421,"median":46.18704,"eighty":73.94997,"marketCap":161812599},{"date":"2023-09-08","current":61.547222,"twenty":-1.529421,"median":46.18704,"eighty":72.141034,"marketCap":158176361},{"date":"2023-09-15","current":65.791858,"twenty":-1.529421,"median":46.18704,"eighty":69.528611,"marketCap":169085076},{"date":"2023-09-22","current":65.320232,"twenty":-1.529421,"median":46.18704,"eighty":68.654713,"marketCap":167872996},{"date":"2023-09-29","current":65.320232,"twenty":-1.529421,"median":46.18704,"eighty":67.577398,"marketCap":167872996},{"date":"2023-10-06","current":61.193503,"twenty":-1.529421,"median":46.18704,"eighty":66.814448,"marketCap":157267302},{"date":"2023-10-13","current":61.075596,"twenty":-1.529421,"median":46.18704,"eighty":66.334228,"marketCap":156964282},{"date":"2023-10-20","current":62.372568,"twenty":-1.529421,"median":46.18704,"eighty":65.862602,"marketCap":160297500},{"date":"2023-10-27","current":66.145578,"twenty":-1.534597,"median":46.166495,"eighty":65.746359,"marketCap":169994135},{"date":"2023-11-03","current":-13.321755,"twenty":-1.543339,"median":46.14415,"eighty":65.169952,"marketCap":161206560},{"date":"2023-11-10","current":-14.773966,"twenty":-1.598875,"median":46.020786,"eighty":65.169952,"marketCap":178779759},{"date":"2023-11-17","current":-16.755533,"twenty":-1.655259,"median":45.902115,"eighty":65.169952,"marketCap":202758708},{"date":"2023-11-24","current":-17.156863,"twenty":-1.781457,"median":45.740146,"eighty":65.169952,"marketCap":207615204},{"date":"2023-12-01","current":-16.605034,"twenty":-1.961222,"median":45.475761,"eighty":65.169952,"marketCap":200937522},{"date":"2023-12-08","current":-16.529785,"twenty":-2.047347,"median":45.215397,"eighty":65.169952,"marketCap":200026929},{"date":"2023-12-15","current":-17.232113,"twenty":-2.144839,"median":45.028503,"eighty":65.169952,"marketCap":208525797},{"date":"2023-12-22","current":-18.034773,"twenty":-2.183245,"median":44.796795,"eighty":65.169952,"marketCap":218238789},{"date":"2023-12-29","current":-18.511353,"twenty":-2.225197,"median":44.719559,"eighty":65.169952,"marketCap":224005878},{"date":"2024-01-05","current":-18.8876,"twenty":-2.245286,"median":44.438185,"eighty":65.169952,"marketCap":228558843},{"date":"2024-01-12","current":-19.21368,"twenty":-2.286056,"median":44.178908,"eighty":65.169952,"marketCap":232504746},{"date":"2024-01-19","current":-19.238763,"twenty":-2.316781,"median":44.056763,"eighty":65.169952,"marketCap":232808277},{"date":"2024-01-26","current":-20.116673,"twenty":-2.34987,"median":43.653879,"eighty":65.169952,"marketCap":243431862},{"date":"2024-02-02","current":-19.740426,"twenty":-2.385912,"median":43.103948,"eighty":65.169952,"marketCap":238878897},{"date":"2024-02-09","current":-19.740426,"twenty":-2.455043,"median":42.980987,"eighty":65.169952,"marketCap":238878897},{"date":"2024-02-16","current":-22.301555,"twenty":-2.523583,"median":42.851878,"eighty":65.169952,"marketCap":269871123},{"date":"2024-02-23","current":-21.06258,"twenty":-2.574398,"median":42.347739,"eighty":65.169952,"marketCap":254878282},{"date":"2024-03-01","current":-21.871707,"twenty":-2.876921,"median":42.133223,"eighty":65.169952,"marketCap":264669525},{"date":"2024-03-08","current":-15.655581,"twenty":-3.057007,"median":41.810704,"eighty":65.169952,"marketCap":273236862},{"date":"2024-03-15","current":-15.692143,"twenty":-3.161168,"median":41.591507,"eighty":65.169952,"marketCap":273874977},{"date":"2024-03-22","current":-16.938387,"twenty":-3.187861,"median":41.205328,"eighty":65.169952,"marketCap":295625675},{"date":"2024-03-28","current":-16.868176,"twenty":-3.221453,"median":40.566036,"eighty":65.169952,"marketCap":294400283},{"date":"2024-04-05","current":-16.731183,"twenty":-3.267014,"median":37.783093,"eighty":65.169952,"marketCap":292009339},{"date":"2024-04-12","current":-16.397613,"twenty":-3.333763,"median":37.318357,"eighty":65.169952,"marketCap":286187537},{"date":"2024-04-19","current":-15.69536,"twenty":-3.378883,"median":36.574778,"eighty":65.169952,"marketCap":273931112},{"date":"2024-04-26","current":-15.484684,"twenty":-3.479225,"median":36.046922,"eighty":65.169952,"marketCap":270254184},{"date":"2024-05-03","current":-24.679518,"twenty":-14.643533,"median":35.751911,"eighty":65.169952,"marketCap":283123431},{"date":"2024-05-10","current":-25.18496,"twenty":-14.733832,"median":35.700839,"eighty":65.169952,"marketCap":288921858},{"date":"2024-05-17","current":-22.512601,"twenty":-14.733832,"median":35.700839,"eighty":65.169952,"marketCap":258264554},{"date":"2024-05-24","current":-23.295413,"twenty":-14.733832,"median":35.700839,"eighty":65.169952,"marketCap":267244976},{"date":"2024-05-31","current":-22.89051,"twenty":-14.733832,"median":35.700839,"eighty":65.169952,"marketCap":262599931},{"date":"2024-06-07","current":-22.701555,"twenty":-14.733832,"median":35.700839,"eighty":65.169952,"marketCap":260432242},{"date":"2024-06-14","current":-22.512601,"twenty":-14.6636,"median":35.709899,"eighty":65.169952,"marketCap":258264554},{"date":"2024-06-21","current":-21.351879,"twenty":-14.622571,"median":35.751911,"eighty":65.169952,"marketCap":244948756},{"date":"2024-06-28","current":-22.242665,"twenty":-5.510975,"median":35.843284,"eighty":65.200008,"marketCap":255167857},{"date":"2024-07-05","current":-21.999724,"twenty":-5.510975,"median":35.843284,"eighty":65.200008,"marketCap":252380829},{"date":"2024-07-12","current":-23.538355,"twenty":-5.510975,"median":35.843284,"eighty":65.200008,"marketCap":270032004},{"date":"2024-07-15","current":-23.835283,"twenty":-5.510975,"median":35.843284,"eighty":65.200008,"marketCap":273438371},{"date":"2024-08-02","current":-57.684056,"twenty":-3.353104,"median":36.249462,"eighty":65.485645,"marketCap":313801264},{"date":"2024-08-09","current":-55.691023,"twenty":-3.38056,"median":35.962899,"eighty":65.155707,"marketCap":302959167},{"date":"2024-08-16","current":-62.581222,"twenty":-3.494296,"median":35.700839,"eighty":64.825025,"marketCap":340441845},{"date":"2024-08-23","current":-66.225624,"twenty":-14.703733,"median":35.063311,"eighty":64.494819,"marketCap":360267394},{"date":"2024-08-30","current":-66.225624,"twenty":-15.072214,"median":34.712018,"eighty":64.259073,"marketCap":360267394},{"date":"2024-09-06","current":-61.556233,"twenty":-15.600869,"median":34.575584,"eighty":64.085926,"marketCap":334865910},{"date":"2024-09-13","current":-60.702077,"twenty":-15.689275,"median":34.241772,"eighty":63.911886,"marketCap":330219297},{"date":"2024-09-20","current":-61.95484,"twenty":-15.784482,"median":34.109564,"eighty":63.551634,"marketCap":337034329},{"date":"2024-09-27","current":-64.004816,"twenty":-16.024772,"median":33.889218,"eighty":63.315821,"marketCap":348186200},{"date":"2024-10-04","current":-63.264547,"twenty":-16.215721,"median":33.352194,"eighty":63.16056,"marketCap":344159136},{"date":"2024-10-11","current":-62.979828,"twenty":-16.344274,"median":32.928413,"eighty":62.862968,"marketCap":342610265},{"date":"2024-10-18","current":-70.097801,"twenty":-16.504702,"median":32.559025,"eighty":62.348987,"marketCap":381332040},{"date":"2024-10-25","current":-61.897896,"twenty":-16.551507,"median":31.254987,"eighty":61.783035,"marketCap":336724555},{"date":"2024-10-31","current":30.568984,"twenty":-16.705367,"median":30.488368,"eighty":61.176839,"marketCap":344176190},{"date":"2024-11-08","current":25.063897,"twenty":-16.73045,"median":30.161726,"eighty":60.04908,"marketCap":282194412},{"date":"2024-11-15","current":24.816012,"twenty":-16.73045,"median":29.608495,"eighty":58.261225,"marketCap":279403478},{"date":"2024-11-22","current":25.20161,"twenty":-16.73045,"median":26.210799,"eighty":57.406537,"marketCap":283744931},{"date":"2024-11-29","current":25.642294,"twenty":-16.73045,"median":25.807551,"eighty":56.765521,"marketCap":288706591},{"date":"2024-12-06","current":25.20161,"twenty":-16.73045,"median":25.642294,"eighty":56.053281,"marketCap":283744931},{"date":"2024-12-13","current":25.036354,"twenty":-16.73045,"median":25.449495,"eighty":55.546658,"marketCap":281884308},{"date":"2024-12-20","current":24.237614,"twenty":-16.73045,"median":25.284239,"eighty":55.430451,"marketCap":272891300},{"date":"2024-12-27","current":25.036354,"twenty":-16.73045,"median":25.20161,"eighty":55.430451,"marketCap":281884308},{"date":"2025-01-03","current":24.457956,"twenty":-16.73045,"median":25.050349,"eighty":55.314245,"marketCap":275372130},{"date":"2025-01-10","current":24.705841,"twenty":-16.730597,"median":24.99504,"eighty":54.843684,"marketCap":278163063},{"date":"2025-01-17","current":26.138064,"twenty":-16.730597,"median":24.953726,"eighty":54.569464,"marketCap":294288458},{"date":"2025-01-24","current":27.267316,"twenty":-16.730597,"median":24.953726,"eighty":54.201458,"marketCap":307002712},{"date":"2025-01-31","current":27.708,"twenty":-16.730597,"median":24.953726,"eighty":53.997424,"marketCap":311964372},{"date":"2025-02-07","current":27.652915,"twenty":-16.730597,"median":24.953726,"eighty":53.588326,"marketCap":311344165},{"date":"2025-02-14","current":27.873257,"twenty":-16.730597,"median":24.953726,"eighty":53.150984,"marketCap":313824995},{"date":"2025-02-21","current":27.763086,"twenty":-16.730597,"median":24.953726,"eighty":52.862447,"marketCap":312584580},{"date":"2025-02-28","current":26.716461,"twenty":-16.730597,"median":24.953726,"eighty":51.990553,"marketCap":300800637},{"date":"2025-03-07","current":16.864488,"twenty":-16.730743,"median":24.926183,"eighty":51.799126,"marketCap":319716966},{"date":"2025-03-14","current":16.336101,"twenty":-16.730743,"median":24.816012,"eighty":51.799126,"marketCap":309699809},{"date":"2025-03-21","current":16.385208,"twenty":-16.730743,"median":24.760926,"eighty":51.799126,"marketCap":310630770},{"date":"2025-03-28","current":17.727453,"twenty":-16.730743,"median":24.705841,"eighty":51.799126,"marketCap":336077047},{"date":"2025-04-04","current":16.368839,"twenty":-16.730743,"median":24.705841,"eighty":51.799126,"marketCap":310320450},{"date":"2025-04-11","current":15.059332,"twenty":-16.730597,"median":24.69207,"eighty":51.789484,"marketCap":285494814},{"date":"2025-04-17","current":15.173914,"twenty":-16.730597,"median":24.69207,"eighty":51.789484,"marketCap":287667057},{"date":"2025-04-25","current":15.324307,"twenty":-16.730743,"median":24.705841,"eighty":51.799126,"marketCap":290518213},{"date":"2025-05-02","current":15.126148,"twenty":-16.730743,"median":24.705841,"eighty":51.799126,"marketCap":286761512},{"date":"2025-05-09","current":16.514034,"twenty":-16.730743,"median":24.705841,"eighty":51.799126,"marketCap":244027880},{"date":"2025-05-12","current":16.579762,"twenty":-16.730743,"median":24.705841,"eighty":51.799126,"marketCap":244999145}],"updateTime":1747193845522}}}